Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Thuris is focused on pharmaceuticals to treat select Orphan and niche indications in-house, ranging from ischemia-related conditions, brain inflammation, and Huntington’s disease. The future pursuit of Alzheimer’s disease and Mild Cognitive Impairment will be in alliance with pharmaceutical partners. Thuris’ drug development efforts originated from the Company’s in vitro and in vivo animal models that recreate the hallmarks (including brain inflammation, neuronal inclusions, neurofibrillary tangles, amyloid toxicity, etc.) of major neurodegenerative diseases in just days — a significant leap forward for neuroprotective drug development. Such advances have enabled Thuris to focus on developing mechanism-based compounds to treat select ( www.thuris.com )
Thuris Corporation
101 Theory
Irvine, California 92612
USA
Tel: (949) 417-4623
Fax: (949) 679-4069